120 related articles for article (PubMed ID: 9106400)
1. Presence of papillomavirus infections in genital lesions of women in Romania.
Stoian M; Anton G; Achim R; Repanovici R
Rom J Virol; 1995; 46(1-2):43-50. PubMed ID: 9106400
[TBL] [Abstract][Full Text] [Related]
2. Clinical and epidemiological correlations between the infection with HPV 16 and HPV 18 and female cervical lesions.
Stoian M; Repanovici R; Corniţescu F
Rom J Virol; 1995; 46(3-4):161-70. PubMed ID: 9179967
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
4. [Early anti-HPV 16 protein antibodies in patients with anogenital tumors].
Marcheş F; Stoian M; Repanovici R
Rev Roum Virol; 1992; 43(3-4):149-54. PubMed ID: 1339204
[TBL] [Abstract][Full Text] [Related]
5. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?
Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):799-805. PubMed ID: 9332762
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus and cervical carcinogenesis.
Stanley MA
Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):663-76. PubMed ID: 11563866
[TBL] [Abstract][Full Text] [Related]
7. Serological study in Tunisian cervical cancer patients.
Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus DNA is present in a subset of unselected breast cancers.
Liu Y; Klimberg VS; Andrews NR; Hicks CR; Peng H; Chiriva-Internati M; Henry-Tillman R; Hermonat PL
J Hum Virol; 2001; 4(6):329-34. PubMed ID: 12082399
[TBL] [Abstract][Full Text] [Related]
9. Genital viral infections. Studies on human papillomavirus and Epstein-Barr virus.
Voog E
Acta Derm Venereol Suppl (Stockh); 1996; 198():1-55. PubMed ID: 9111847
[TBL] [Abstract][Full Text] [Related]
10. HPV-16-related proteins as the serologic markers in cervical neoplasia.
Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
[TBL] [Abstract][Full Text] [Related]
11. Increase of genital human papillomavirus infection among men and women in Croatia.
Grce M; Magdić L; Kocijan I; Pavelić K
Anticancer Res; 1996; 16(2):1039-41. PubMed ID: 8687096
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas.
Szkaradkiewicz A; Kruk-Zagajewska A; Wal M; Jopek A; Wierzbicka M; Kuch A
Clin Exp Med; 2002 Nov; 2(3):137-41. PubMed ID: 12447611
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
[TBL] [Abstract][Full Text] [Related]
15. Identification of antibodies against human papillomavirus type 16 E4 and E7 proteins in sera of patients with cervical neoplasias.
Stoian M; Repanovici R
Rev Roum Virol; 1994; 45(3-4):185-92. PubMed ID: 7619739
[TBL] [Abstract][Full Text] [Related]
16. [The detection of human papillomaviruses in histological preparations by using dot-blot hybridization].
Anton G; Stoian M; Iliescu R; Popa LM; Repanovici R
Rev Roum Virol; 1992; 43(3-4):141-8. PubMed ID: 1339203
[TBL] [Abstract][Full Text] [Related]
17. Determinants of genital human papillomavirus detection in a US population.
Peyton CL; Gravitt PE; Hunt WC; Hundley RS; Zhao M; Apple RJ; Wheeler CM
J Infect Dis; 2001 Jun; 183(11):1554-64. PubMed ID: 11343204
[TBL] [Abstract][Full Text] [Related]
18. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
[TBL] [Abstract][Full Text] [Related]
19. Demographic and risk factors in patients with head and neck tumors.
Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E
J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944
[TBL] [Abstract][Full Text] [Related]
20. HPV detection in cervical cancer patients in northern Poland.
Dybikowska A; Licznerski P; Podhajska A
Oncol Rep; 2002; 9(4):871-4. PubMed ID: 12066224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
